THE FDA PERSPECTIVE ON THE DEVELOPMENT OF STEREOISOMERS

被引:279
作者
DECAMP, WH
机构
关键词
D O I
10.1002/chir.530010103
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
引用
收藏
页码:2 / 6
页数:5
相关论文
共 31 条
[1]
BIAS IN PHARMACOKINETICS AND CLINICAL-PHARMACOLOGY [J].
ARIENS, EJ ;
WUIS, EW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (04) :361-363
[2]
STEREOCHEMISTRY - A SOURCE OF PROBLEMS IN MEDICINAL CHEMISTRY [J].
ARIENS, EJ .
MEDICINAL RESEARCH REVIEWS, 1986, 6 (04) :451-466
[3]
STEREOCHEMISTRY, A BASIS FOR SOPHISTICATED NONSENSE IN PHARMACOKINETICS AND CLINICAL-PHARMACOLOGY [J].
ARIENS, EJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :663-668
[4]
BLASCHKE G, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1640
[5]
CHROMATOGRAPHIC RESOLUTIONS OF RACEMATES .10. OPTICAL RESOLUTION OF THALIDOMIDE AND OTHER GLUTARIMIDE DERIVATIVES [J].
BLASCHKE, G ;
KRAFT, HP ;
MARKGRAF, H .
CHEMISCHE BERICHTE-RECUEIL, 1980, 113 (06) :2318-2322
[6]
BOPP RJ, 1979, DRUG METAB DISPOS, V7, P356
[7]
SPECIFICATION OF MOLECULAR CHIRALITY [J].
CAHN, RS ;
INGOLD, C ;
PRELOG, V .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1966, 5 (04) :385-&
[8]
CASINI G, 1964, FARM ED SCI, V219, P563
[9]
DERANTER CJ, 1984, XRAY CRYSTALLOGRAPHY, P3